Sanofi buys into Indian biotech
Sanofi-Aventis, France’s largest drugmaker, has made its first direct investment in the Indian biotech sector with the acquisition of a 78 per cent stake in Shantha Biotechnics, an Indian vaccine maker, for €429m ($613m). http://www.ft.com/cms/s/0/4f13effe-7b0d-11de-8c34-00144feabdc0.html